Publications by authors named "Emma Accorsi"

Before October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a pneumococcal conjugate vaccine (PCV) for all adults aged ≥65 years, as well as for those aged 19-64 years with risk conditions for pneumococcal disease who have not received a PCV or whose vaccination history is unknown. Options included either 20-valent PCV (PCV20; Prevnar20; Wyeth Pharmaceuticals) or 21-valent PCV (PCV21; CAPVAXIVE; Merck Sharp & Dohme) alone or 15-valent PCV (PCV15; VAXNEUVANCE; Merck Sharp & Dohme) in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23; Pneumovax23; Merck Sharp & Dohme). There are additional recommendations for use of PCV20 or PCV21 for adults who started their pneumococcal vaccination series with 13-valent PCV (PCV13; Prevnar13; Wyeth Pharmaceuticals).

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the effectiveness of mRNA monovalent booster doses against new SARS-CoV-2 subvariants BA.2/BA.2.12.1 and BA.4/BA.5, which have mutations allowing them to evade immunity better than previous variants.
  • Data from over 760,000 cases and 817,000 controls showed that three vaccine doses provided 45% to 74% effectiveness against symptomatic COVID-19 in individuals over 12 years old, but this protection decreased to 0% within 5-7 months.
  • For adults aged 50 and older, those who received four doses had ongoing protection against infection, with effectiveness remaining significant at over 3 months
View Article and Find Full Text PDF
Article Synopsis
  • On June 18, 2022, ACIP recommended the 2-dose Moderna vaccine for children 6 months-5 years and the 3-dose Pfizer-BioNTech vaccine for those 6 months-4 years based on safety and limited efficacy data.
  • Studies showed that the effectiveness of Moderna's vaccine in children aged 3-5 was 60% two weeks to two months after the second dose, while Pfizer's vaccine for children aged 3-4 had an effectiveness of 31% within two to four months after the third dose.
  • The CDC later expanded vaccine recommendations to include updated bivalent vaccines for children aged 6 months and older on December 9, 2022, to improve protection against current COVID
View Article and Find Full Text PDF
Article Synopsis
  • * A nationwide survey of 4,510 U.S. adults revealed that those who tested positive for COVID-19 had a higher likelihood of reporting long-term symptoms, with no significant difference between those with and without disabilities.
  • * However, adults with disabilities who tested positive utilized health care services for ongoing symptoms more than those without disabilities (40% vs. 18%).
View Article and Find Full Text PDF
Article Synopsis
  • On September 1, 2022, ACIP recommended bivalent COVID-19 mRNA vaccines targeting both the ancestral and Omicron BA.4/BA.5 strains to improve immunity following monovalent vaccine use.
  • Initially, these vaccines were recommended for individuals aged 12 and older, later expanding to children aged 5-11 on October 12, 2022, though clinical efficacy data were lacking at that time.
  • A study analyzed the effectiveness of the bivalent booster, showing varying degrees of protection against symptomatic SARS-CoV-2 infection, with higher relative vaccine effectiveness found in individuals aged 18-49 compared to older age groups.
View Article and Find Full Text PDF

In May 2022, CDC learned of three children in California hospitalized concurrently for brain abscess, epidural empyema, or subdural empyema caused by Streptococcus intermedius. Discussions with clinicians in multiple states raised concerns about a possible increase in pediatric intracranial infections, particularly those caused by Streptococcus bacteria, during the past year and the possible contributing role of SARS-CoV-2 infection (1). Pediatric bacterial brain abscesses, epidural empyemas, and subdural empyemas, rare complications of respiratory infections and sinusitis, are often caused by Streptococcus species but might also be polymicrobial or caused by other genera, such as Staphylococcus.

View Article and Find Full Text PDF

Background: The role of diet on Coronavirus Disease 2019 (COVID-19) is emerging. We investigated the association between usual diet before the onset of the pandemic and risk and severity of subsequent SARS-CoV-2 infection.

Methods: We included 42,935 participants aged 55-99 y in 2 ongoing cohort studies, the Nurses' Health Study II and Health Professionals Follow-up Study, who completed a series of COVID-19 surveys in 2020 and 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Disruption of microbial communities and their bioactive compounds is linked to inflammatory bowel diseases (IBD), with many microbial proteins remaining uncharacterized despite their potential bioactivity.
  • Researchers identified over 340,000 protein families possibly involved in gut inflammation related to IBD, with a significant portion previously uncharacterized, using a combination of metagenomic techniques.
  • The new methodology, called MetaWIBELE, helped validate findings and revealed that specific microbial proteins could influence host immune responses, offering insights into potential therapeutic targets for chronic diseases like IBD.
View Article and Find Full Text PDF
Article Synopsis
  • * A study used data from nearly 75,000 tests involving children and adolescents to assess the vaccine's effectiveness during the Omicron surge by comparing vaccinated individuals to those unvaccinated.
  • * The analysis included significant sample sizes, revealing important insights into the relationship between prior vaccination and the occurrence of symptomatic COVID-19 infections among youth during a key period.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to assess the effectiveness of three COVID-19 vaccines (BNT162b2, mRNA-1273, and Ad26.COV2.S) over time and during the Delta variant surge to inform vaccination strategies.
  • Data was collected from 6884 US testing sites, involving over 1.8 million tests to analyze the correlation between symptomatic SARS-CoV-2 infections and vaccination status in adults and adolescents from March to October 2021.
  • Results showed that the odds of symptomatic infection post-vaccination increased over time, particularly during the Delta variant period, indicating a reduced effectiveness of vaccines in preventing infections as time since vaccination lengthened.
View Article and Find Full Text PDF

Importance: Assessing COVID-19 vaccine performance against the rapidly spreading SARS-CoV-2 Omicron variant is critical to inform public health guidance.

Objective: To estimate the association between receipt of 3 doses of Pfizer-BioNTech BNT162b2 or Moderna mRNA-1273 vaccine and symptomatic SARS-CoV-2 infection, stratified by variant (Omicron and Delta).

Design, Setting, And Participants: A test-negative case-control analysis among adults 18 years or older with COVID-like illness tested December 10, 2021, through January 1, 2022, by a national pharmacy-based testing program (4666 COVID-19 testing sites across 49 US states).

View Article and Find Full Text PDF

Since March 2020, the United States has lost over 580,000 lives to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. A growing body of literature describes population-level SARS-CoV-2 exposure, but studies of antibody seroprevalence within school systems are critically lacking, hampering evidence-based discussions on school reopenings. The Lake Central School Corporation (LCSC), a public school system in suburban Indiana, USA, assessed SARS-CoV-2 seroprevalence in its staff and identified correlations between seropositivity and subjective histories and demographics.

View Article and Find Full Text PDF

In response to the coronavirus disease (COVID-19) pandemic, public health scientists have produced a large and rapidly expanding body of literature that aims to answer critical questions, such as the proportion of the population in a geographic area that has been infected; the transmissibility of the virus and factors associated with high infectiousness or susceptibility to infection; which groups are the most at risk of infection, morbidity and mortality; and the degree to which antibodies confer protection to re-infection. Observational studies are subject to a number of different biases, including confounding, selection bias, and measurement error, that may threaten their validity or influence the interpretation of their results. To assist in the critical evaluation of a vast body of literature and contribute to future study design, we outline and propose solutions to biases that can occur across different categories of observational studies of COVID-19.

View Article and Find Full Text PDF

Background: High-throughput sequencing provides a powerful window into the structural and functional profiling of microbial communities, but it is unable to characterize only the viable portion of microbial communities at scale. There is as yet not one best solution to this problem. Previous studies have established viability assessments using propidium monoazide (PMA) treatment coupled with downstream molecular profiling (e.

View Article and Find Full Text PDF

Background: Staphylococcus aureus is a leading cause of healthcare- and community-associated infections and can be difficult to treat due to antimicrobial resistance. About 30% of individuals carry S. aureus asymptomatically in their nares, a risk factor for later infection, and interactions with other species in the nasal microbiome likely modulate its carriage.

View Article and Find Full Text PDF

Background: Since March 2020, the United States has lost over 200,000 lives to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. A growing body of literature describes population-level SARS-CoV-2 exposure, but studies of antibody seroprevalence within school systems are critically lacking, hampering evidence-based discussions on school reopenings. The Lake Central School Corporation (LCSC), a public school system in suburban Indiana, USA, assessed SARS-CoV-2 seroprevalence in its staff and identified correlations between seropositivity and subjective histories and demographics.

View Article and Find Full Text PDF

Facing the onset of the COVID-19 pandemic and increasing outbreaks among farmworkers and food processing workers across the nation, the Oregon Occupational Health and Safety Administration (OR OSHA) issued temporary regulations, in contrast to optional recommendations, in late spring. These regulations aimed to reduce the risk of COVID-19 transmission among farmworkers, but made compromises that may fail to reduce the risk of further outbreaks among Oregon's agricultural workers, particularly those living in agricultural labor housing. Instead of considering the scientific literature that called for attention to space and length of time for social distancing among unrelated persons in indoor areas, the agency accepted the 6-foot social distancing rule of thumb and allowed even shorter distances between beds with the installation of plastic or plywood barriers.

View Article and Find Full Text PDF